FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061238696> ?p ?o ?g. }

• W2061238696 abstract "A historical perspective on methylglyoxal research is briefly presented, mentioning the documented anticancer and antiviral effects of methylglyoxal. The idea and the supporting experimental evidence of Albert Szent-Györgyi et al. that methylglyoxal is a natural growth regulator and can act as an anticancer agent are mentioned. Previously a few in vivo studies suggested safe administration of methylglyoxal. However, recent literature abounds with the toxic effects of methylglyoxal. The authors present a brief critical overview of studies indicating both toxic and beneficial effects of methylglyoxal and suggest that the beneficial effects of methylglyoxal outweigh its toxic effects. Encouraged by the studies of Szent-Györgyi et al., the present authors undertook systematic investigations to understand the mechanism of the anticancer effect of methylglyoxal. The results of these investigations led to the proposal that the fundamental changes in malignant cells are critical alterations of glyceraldehyde-3-phosphate dehydrogenase and mitochondrial complex I, and methylglyoxal's anticancer effect might be mediated by acting on these altered sites. Moreover, a new hypothesis on cancer has been proposed, suggesting that excessive ATP formation in cells may lead to malignancy. Toxicity and pharmacokinetic studies were performed on animals and it was observed that methylglyoxal is potentially safe for humans. A methylglyoxal-based anticancer formulation was developed and a three-phase study of treating a total number of 86 cancer patients was carried out. The results appear to be promising. Most of the cancer patients benefited greatly and a significant number of patients became free of the disease. Contrary to the effect of existing anticancer drugs, this methylglyoxal-based formulation is devoid of any toxic effect and reasonably effective against a wide variety of cancers. The symptomatic improvements of the many patients who died of progressive disease suggest that the formulation could also be used for palliation. The authors urge the scientific community to test the formulation and if found effective then to improve it further." @default.
• W2061238696 created "2016-06-24" @default.
• W2061238696 creator A5005955210 @default.
• W2061238696 creator A5044141575 @default.
• W2061238696 creator A5045855363 @default.
• W2061238696 creator A5047278130 @default.
• W2061238696 date "2008-01-01" @default.
• W2061238696 modified "2023-10-04" @default.
• W2061238696 title "A BRIEF CRITICAL OVERVIEW OF THE BIOLOGICAL EFFECTS OF METHYLGLYOXAL AND FURTHER EVALUATION OF A METHYLGLYOXAL-BASED ANTICANCER FORMULATION IN TREATING CANCER PATIENTS" @default.
• W2061238696 cites W118324404 @default.
• W2061238696 cites W120247693 @default.
• W2061238696 cites W1518714662 @default.
• W2061238696 cites W1528840891 @default.
• W2061238696 cites W1609735481 @default.
• W2061238696 cites W1626726851 @default.
• W2061238696 cites W1757241200 @default.
• W2061238696 cites W1776564239 @default.
• W2061238696 cites W1896619220 @default.
• W2061238696 cites W1913619429 @default.
• W2061238696 cites W1945607742 @default.
• W2061238696 cites W1964649339 @default.
• W2061238696 cites W1971267206 @default.
• W2061238696 cites W1972299046 @default.
• W2061238696 cites W1972681776 @default.
• W2061238696 cites W1977154399 @default.
• W2061238696 cites W1982108497 @default.
• W2061238696 cites W1989949137 @default.
• W2061238696 cites W2001348757 @default.
• W2061238696 cites W2001605910 @default.
• W2061238696 cites W2003817153 @default.
• W2061238696 cites W2006088447 @default.
• W2061238696 cites W2008463780 @default.
• W2061238696 cites W2015140913 @default.
• W2061238696 cites W2019970574 @default.
• W2061238696 cites W2021983599 @default.
• W2061238696 cites W2024310939 @default.
• W2061238696 cites W2025430773 @default.
• W2061238696 cites W2025967280 @default.
• W2061238696 cites W2032457228 @default.
• W2061238696 cites W2034484030 @default.
• W2061238696 cites W2037822595 @default.
• W2061238696 cites W2038419425 @default.
• W2061238696 cites W2038516205 @default.
• W2061238696 cites W2044437167 @default.
• W2061238696 cites W2050640058 @default.
• W2061238696 cites W2052045892 @default.
• W2061238696 cites W2055081817 @default.
• W2061238696 cites W2058525009 @default.
• W2061238696 cites W2061418097 @default.
• W2061238696 cites W2061895500 @default.
• W2061238696 cites W2064279444 @default.
• W2061238696 cites W2064382404 @default.
• W2061238696 cites W2068418661 @default.
• W2061238696 cites W2071540582 @default.
• W2061238696 cites W2072488939 @default.
• W2061238696 cites W2072900154 @default.
• W2061238696 cites W2077034296 @default.
• W2061238696 cites W2087854721 @default.
• W2061238696 cites W2091103817 @default.
• W2061238696 cites W2091430856 @default.
• W2061238696 cites W2092768981 @default.
• W2061238696 cites W2095480688 @default.
• W2061238696 cites W2097792751 @default.
• W2061238696 cites W2113746520 @default.
• W2061238696 cites W2132153731 @default.
• W2061238696 cites W2150094500 @default.
• W2061238696 cites W2156599039 @default.
• W2061238696 cites W2156890825 @default.
• W2061238696 cites W2166523410 @default.
• W2061238696 cites W2167366356 @default.
• W2061238696 cites W2178215137 @default.
• W2061238696 cites W28486177 @default.
• W2061238696 cites W4239951311 @default.
• W2061238696 doi "https://doi.org/10.1515/dmdi.2008.23.1-2.175" @default.
• W2061238696 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18533369" @default.
• W2061238696 hasPublicationYear "2008" @default.
• W2061238696 type Work @default.
• W2061238696 sameAs 2061238696 @default.
• W2061238696 citedByCount "30" @default.
• W2061238696 countsByYear W20612386962012 @default.
• W2061238696 countsByYear W20612386962013 @default.
• W2061238696 countsByYear W20612386962014 @default.
• W2061238696 countsByYear W20612386962015 @default.
• W2061238696 countsByYear W20612386962016 @default.
• W2061238696 countsByYear W20612386962017 @default.
• W2061238696 countsByYear W20612386962018 @default.
• W2061238696 countsByYear W20612386962020 @default.
• W2061238696 countsByYear W20612386962021 @default.
• W2061238696 crossrefType "journal-article" @default.
• W2061238696 hasAuthorship W2061238696A5005955210 @default.
• W2061238696 hasAuthorship W2061238696A5044141575 @default.
• W2061238696 hasAuthorship W2061238696A5045855363 @default.
• W2061238696 hasAuthorship W2061238696A5047278130 @default.
• W2061238696 hasConcept C121608353 @default.
• W2061238696 hasConcept C126322002 @default.
• W2061238696 hasConcept C181199279 @default.
• W2061238696 hasConcept C185592680 @default.
• W2061238696 hasConcept C2778592357 @default.
• W2061238696 hasConcept C55493867 @default.
• W2061238696 hasConcept C71924100 @default.

• next